Description
Product Overview / 商品概要
TOBI Inhalation Solution 300mg (トービイ吸入液300mg)
Generic: Tobramycin / トブラマイシン
Therapeutic Category: Aminoglycoside Antibiotic / アミノグリコシド系抗生物質製剤
Manufactured by: Viatris Pharmaceuticals LLC / ヴィアトリス製薬合同会社
Composition & Specification / 組成・規格
Active Ingredient: Tobramycin 300.00mg (potency) per vial / 1管中 トブラマイシン 300.00mg(力価)
Additives: Sodium chloride, pH adjuster / 塩化ナトリウム、pH調節剤
Appearance: Slightly yellowish clear solution, pH 5.5–6.5
外観: 微黄色澄明の液、pH 5.5~6.5
Indications / 効能効果
EN: Improvement of symptoms associated with respiratory infections caused by Pseudomonas aeruginosa in cystic fibrosis
JA: 嚢胞性線維症における緑膿菌による呼吸器感染に伴う症状の改善
Dosage and Administration / 用法用量
EN: Inhale 300mg twice daily for 28 days via nebulization, followed by a 28-day off period. Repeat this cycle.
JA: 1回300mgを1日2回28日間噴霧吸入する。その後28日間休薬する。これを1サイクルとして投与を繰り返す。
Contraindications / 禁忌
EN: Patients with a history of hypersensitivity to any component of this product, other aminoglycoside antibiotics, or bacitracin
JA: 本剤の成分並びに他のアミノグリコシド系抗生物質又はバシトラシンに対し過敏症の既往歴のある患者
Regulatory Information / 規制情報
Approval No.: 22400AMX01384
Sales Started: January 2013 / 2013年1月
Classification Code: 876123
Storage: Store at 2–8°C / 2~8℃に保存
Shelf Life: 3 years / 3年
Packaging / 包装
Main Package (for sale): 5mL x 14 vials (aluminum bag) / 5mL×14管(アルミ袋)
Other Available Packages (by special order): 5mL x 14 vials (aluminum bag)
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.


![Ofloxacin Otic Solution 0.3% [CEO] (Ofloxacin Otic Solution CEO® / オフロキサシン耳科用液0.3%「CEO」)](https://jp-pharma.com/wp-content/uploads/2026/06/OFL-03-OTC_1200x1200-324x324.jpg)

Reviews
There are no reviews yet.